INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Unspecified Childhood Solid Tumor, Protocol SpecificInterventions:   Drug: ruxolitinib phosphate;   Other: laboratory biomarker analysis;   Other: pharmacological studySponsors:   Children's Oncology Group;   National Cancer Institute (NCI)Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2010 Category: Research Source Type: clinical trials

Registry of Older Patients With Cancer
Conditions:   Chronic Myeloproliferative Disorders;   Cognitive/Functional Effects;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Unspecified Adult Solid Tumor, Protocol SpecificIntervention:   Sponsors:   UNC Lineberger Comprehensive Cancer Center;   National Cancer Institute (NCI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2010 Category: Research Source Type: clinical trials

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Conditions:   Cancer Survivor;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Testicular Germ Cell TumorInterventions:   Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysisSponsors:   Vanderbilt University;   National Cancer Institute (NCI)Terminated - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2010 Category: Research Source Type: clinical trials

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell TumorIntervention:   Dietary Supplement: Lactobacillus rhamnosus GGSponsors:   Rutgers, The State University of New Jersey;   National Cancer Institute (NCI);   Rutgers Cancer Institute of New JerseyActive, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2009 Category: Research Source Type: clinical trials

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell TumorIntervention:   Dietary Supplement: Lactobacillus rhamnosus GGSponsors:   Rutgers, The State University of New Jersey;   National Cancer Institute (NCI);   Rutgers Cancer Institute of New JerseyActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2009 Category: Research Source Type: clinical trials

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell TumorIntervention:   Dietary Supplement: Lactobacillus rhamnosus GGSponsors:   Rutgers, The State University of New Jersey;   National Cancer Institute (NCI);   Rutgers Cancer Institute of New JerseyActive, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2009 Category: Research Source Type: clinical trials

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Conditions:   Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Unspecified Adult Solid Tumor, Protocol SpecificIntervention:   Device: 3'-deoxy-3'-[18F]fluorothymidineSponsors:   Barbara Ann Karmanos Cancer Institute;   National Cancer Institute (NCI)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2009 Category: Research Source Type: clinical trials